Tag: ASX: OIL
Optiscan taps US manufacturer Long Grove Pharmaceuticals for surgical imaging partnership
Optiscan Imaging has entered a five-year collaboration with US drug manufacturer Long Grove Pharmaceuticals to jointly develop new clinical applications for the fluorescein sodium contrast agent used in surgical imaging.
Optiscan advances medical manufacturing with telepathology platform beta test
Optiscan Imaging has completed the beta phase for its cloud-connected telepathology platform, developed in partnership with Prolucid Technologies.
Featured Article
Good Design Australia opens entries for 2026 awards
For more than six decades, Good Design Australia has celebrated the power of design to shape innovation, industry, and everyday life. Its flagship program, the Australian Good Design Awards, recognises projects that show how thoughtful design can enhance products, services, systems, and communities.
